eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 22
Original paper

Prognostic factors of primary fallopian tube carcinoma

Emrah Akkaya, Muzaffer Sanci, Nur G. Kulhan, Mehmet Kulhan, Umit Nayki, Cenk Nayki, Nahit Ata, Pasa Ulug

Contemp Oncol (Pozn) 2018; 22 (2): 99-104
Online publish date: 2018/04/09
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Aim of the study
Fallopian tube cancer is very rare in the literature and so there are not enough data about the therapeutic approaches. The approaches are generally determined in accordance with the data obtained from ovarian cancer. Many prognostic factors have been investigated in an effort to better estimate patient outcome. Stage, age, and residual tumor after surgery are consistently important prognostic factors. In this study, we aimed to evaluate the prognostic factors and survival rates of primary fallopian tube cancer (PFTC), which is rare among gynecological cancers.

Material and methods
Thirty-eight patients with a diagnosis of PFTC were identified through the gynecologic oncology service database of our Research and Training Hospital in the period 1995–2013. Clinicopathological and surgical data were collected. All patients were evaluated for survival and disease-free survival between the dates specified.

A significant relationship and correlation was found between optimal surgery and life expectancy. Better results were obtained in patients treated with optimal surgery. The survival probability was found to be higher in patients with lower CA-125 levels and serous histologic type adenocarcinoma.

Stage is one of the factors affecting the survival probability. We determined that the pathological type of tumor, the diameter of residual tumor remaining after surgery, tumor grade, preoperative CA-125 levels and presence of ascites affect the survival probability.


primary fallopian tube cancer, prognostic factor, management and treatment

Meng ML, Gan-Gao, Scheng-Sun, Bao QC, Jung ZA. Diagnosis of primary adenocarcinoma of the fallopian tube. J Cancer Res Clin Oncol 1985; 110: 136-40.
Baalbaky I, Vinatier D, Leblanc E, Querleu D. Clinical aspects of primary cancer of the fallopian tube. A retrospective study of 20 cases. J Gynecol Obstet Biol Reprod (Paris) 1999; 28: 225-31.
Benoit MF and Hannigan EV. A 10-year reviev of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. Int J Gynecol Cancer 2006; 16: 29-35.
Reyes MC, Arnold AG, Kauff ND, Levine DA, Soslow RA. Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency. Mod Pathol 2014; 27: 1405-11.
Koo YJ, Kwon YS, Lim KT, et al. Para-aortic lymphadenectomy for primary fallopian tube cancer. Int J Gynaecol Obstet 2011; 112: 18-20.
Kalampokas E, Kalampokas T, Tourountous I. Primary fallopian tube carcinoma. Eur J Obstet Gynecol Reprod Biol 2013; 169: 155-61.
Bidus MA, Maxwell GL, Ros GS. Fallopian tube cancer. In: Di Saia PJ, Creasman WT (eds.). Clinical gynecologic oncology. 8th ed. Elsevier/Saunders, Philadelphia 2012; 357-68.
Hu CY, Taymor ML, Hertig AT. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1950; 59: 58-67.
Sedlis A. Carcinoma of the fallopian tube. Surg Clin North Am 1978; 58: 121-9.
Stewart SL, Wike JM, Foster SL, Michaud F. The incidence of primary fallopian tube cancer in the Unıted States. Gynecol Oncol 2007; 107: 392-7.
Clayton NL, Jaaback KS, Hirschowitz L. Primary fallopian tube carcinoma – the experience of a UK cancer centre and a review of the literature. J Obstet Gynecol 2005; 25: 694-702.
Kone M, Body G, Calais G, Fignon A, Fetissof F, Lansac J. Primary adenocarcinoma of the fallopian tube. Retrospective study of 16 cases. Prognostic factors. J Gynecol Obstet Biol Reprod (Paris) 1992; 21: 187-92.
Schneider C, Wight E, Perucchini D, Haller U, Fink D. Primary carcinoma of the fallopian tube. A report of 19 cases with literature review. Eur J Gynaecol Oncol 2000; 21: 578-82.
Alvarado-Cabrero I, Young RH, Vamvakas EC Scully RE. Carcinoma of the fallopian tube: A clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 1999; 72: 367-79.
Ajithkumar TV, Minimole AL, John MM, Ashokkumar OS. Primary fallopian tube carcinoma. Obsest Gynecol Surv 2005; 60: 247-52.
Koo YJ, Im KS, Kwon YS, et al. Primary fallopian tube carcinoma: a clinicopathological analysis of a rare entity. Int J Clin Oncol 2011; 16: 45-9.
Puls LE, Davey DD, DePriest PD, Gallion HH, van Nagell JR Jr, Hunter JE, Pavlik EJ. Immunohistochemical staining for CA 125 in fallopian tube carcinomas. Gynecol Oncol 1993; 48: 360-3.
Rosen AC, Ausch C, Hafner E, Klein M, Lahousen M, Graf AH. A-15 Year Overview of Management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for fallopian tube carcinoma. Eur J Cancer 1998; 34: 1725-9.
Wethington SL, Herzog TJ, Seshan VE, Bansal N, Schiff PB, Burke WM, Cohen CJ, Wright JD. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. Cancer 2008; 113: 298-306.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe